Association of HCV with diabetes mellitus: An Egyptian case-control study

Virology Journal

Volumn 8, Issue , 2011, Pages

  Elhawary, Eman I ^a   Mahmoud, Gamal F ^a   El Daly, Mai A ^b   Mekky, Fatma A ^c   Esmat, Gamal G ^d   Abdel Hamid, Mohamed ^b  

^a Minia University   (Egypt)

^b Molecular Biology Unit   (Egypt)

^c AIN SHAMS UNIVERSITY   (Egypt)

^d CAIRO UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DEMOGRAPHY; DIABETES MELLITUS; DISEASE ASSOCIATION; EGYPT; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER CIRRHOSIS; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PREVALENCE; AGE; COMORBIDITY; GEOGRAPHY; GLUCOSE BLOOD LEVEL; HETEROZYGOTE; LIVER FUNCTION TEST; MIDDLE AGED; RISK FACTOR;

HEPATITIS C VIRUS;

ADULT; AGE FACTORS; BLOOD GLUCOSE; CARRIER STATE; CASE-CONTROL STUDIES; COMORBIDITY; DIABETES MELLITUS; EGYPT; FEMALE; GEOGRAPHY; HEPATITIS C, CHRONIC; HUMANS; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS;

EID: 79960685751     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-8-367     Document Type: Article

References (49)

1. Metabolic investigations in patients with hepatitis B and C. Mastoi AA, Devrajani BR, Shah SZ, Rohopoto Q, Memon SA, Baloch M, Qureshi GA, Sami W, World J Gastroenterol 2010 16 5 603 7 10.3748/wjg.v16.i5.603 20128029
2. Hepatitis C in a community in Upper Egypt: Risk factors for infection. Medhat A, Shehata M, Magder S, Am J Trop Med Hyg 2002 66 633 8 12201604
3. Genetic epidemiology of HCV throughout Egypt. Ray SC, Arthur RR, Carella A, Bukh J, Thomas DL, J Infect Dis 2000 182 698 707 10.1086/315786 10950762
4. The role of parentral antischistosomal therapy in the spread of HCV in Egypt. Frank C, Mohamed MK, Strickland GT, Lavanchy D, Arthur RR, Magder LS, ElKholy T, Abdel-Wahab Y, Aly Ohn ES, Anwar W, Sallam L, Lancet 2000 355 887 91 10.1016/S0140-6736(99)06527-7 10752705 (Pubitemid 30137669)
5. EH manifestations associated with HCV infection. A prospective multicenter study of 321 patients. The GERMIVIC Groupe d'Etude et de Recherche en Medicine Interne et Maladies Infectieuses sur le Virus de l'Hepatite C. Cacoub P, Renou C, Rosenthal E, Cohen P, Loury I, Medicine [Baltimore] 2000 79 47 56 10.1097/00005792-200001000-00005 (Pubitemid 30077736)
6. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Mehta SH, Brancati FL, Sulkowski MS, Strathdee S, Szklo M, Thomas DL, Ann Intern Med 2000 133 592 599 11033586
7. Thyroid disorders in chronic hepatitis C virus infection. Antonelli A, Ferri C, Fallahi P, Ferrari SM, Ghinoi A, Rotondi M, Ferrannini E, Thyroid 2006 16 6 563 72 10.1089/thy.2006.16.563 16839258 (Pubitemid 44066263)
8. Hepatitis C and arthritis: an update. Sanzone AM, Bégué RE, Infect Dis Clin North Am 2006 20 4 877 89 10.1016/j.idc.2006.09.010 17118294 (Pubitemid 44752026)
9. EH manifestations of hepatitis C among U.S. male veterans. El-Serag H, Hampel H, Yeh C, Rabeneck L, Hepatology 2002 36 1439 45 12447870 (Pubitemid 35403535)
10. Extrahepatic manifestations of chronic viral hepatitis. Pyrsopoulos NT, Reddy KR, Curr Gastroenterol Rep 2001 3 1 71 8 Review 10.1007/s11894-001-0044-1 11177698
11. Global and societal implications of the diabetes epidemic. Zimmet P, Alberti KG, Shaw J, Nature 2001 414 782 7 10.1038/414782a 11742409 (Pubitemid 34000780)
12. Long-term lifestyle intervention lowers the incidence of stroke in Japanese patients with type 2 diabetes: a nationwide multicentre randomised controlled trial (the Japan Diabetes Complications Study). Sone H, Tanaka S, Iimuro S, Tanaka S, Oida K, Yamasaki Y, Oikawa S, Ishibashi S, Katayama S, Yamashita H, Ito H, Yoshimura Y, Ohashi Y, Akanuma Y, Yamada N, Japan Diabetes Complications Study Group, Diabetologia 2010 53 3 419 28 10.1007/s00125-009- 1622-2 20054522
13. Sex differences in risk factors for incident type 2 diabetes mellitus: the MONICA Augsburg cohort study. Meisinger C, Thorand B, Schneider A, Stieber J, Döring A, Löwel H, Arch Intern Med 2002 14;162 1 82 9 21788554 (Pubitemid 34073405)
14. Risk factors for the development of diabetes mellitus in chronic hepatitis C virus genotype 4 infection. Chehadeh W, Abdella N, Ben-Nakhi A, Al-Arouj M, Al-Nakib W, J Gastroenterol Hepatol 2009 24 1 42 8 10.1111/j.1440-1746.2008.05503.x 18717762
15. Association between diabetes, overweight, obesity and dyslipidemia with fibrosis progression in chronic hepatitis C patients. Loaeza-del Castillo A, 40th EASL. April13-17, 2005. Paris, France 581
16. Clinical aspects of chronic hepatitis C infection. Schattner A, Knobler H, JAMA 2003 290 11 1453 author reply 1453 4
17. Association of chronic hepatitis C infection and diabetes mellitus. El-Zayadi AR, Selim OE, Hamdy H, Dabbous H, Ahdy A, Moniem SA, Trop Gastroenterol 1998 19 4 141 4 10228436
18. Optimization, assessment, and proposed use of a direct nested reverse transcription-polymerase chain reaction protocol for the detection of hepatitis C virus. Abdel-Hamid M, Edelman DC, Highsmith WE, Constantine NT, J Hum Virol 1997 1 1 58 65 10195232 (Pubitemid 127533732)
19. Diagnosis and classification of Diabetes Mellitus. ADA American Diabetes Association, Diab Care 2008 31 S1, S55-S60
20. Association of hepatitis C virus infection and diabetes in central Tunisia. Kaabia N, Ben Jazia E, Slim I, Fodha I, Hachfi W, Gaha R, Khalifa M, Hadj Kilani A, Trabelsi H, Abdelaziz A, Bahri F, Letaief A, World J Gastroenterol 2009 15 22 2778 81 10.3748/wjg.15.2778 19522029
21. Hepatitis C virus and type 2 diabetes. Negro F, Alaei M, World J Gastroenterol 2009 15 13 1537 1547 10.3748/wjg.15.1537 19340895
22. Risk factors for diabetes mellitus and early insulin resistance in chronic hepatitis C. Petit JM, Bour JB, Galland-Jos C, Minello A, Verges B, Guiguet M, J Hepatology 2001 35 279 283 10.1016/S0168-8278(01)00143-X (Pubitemid 32803485)
23. Hepatitis C virus infection and the development of type 2 diabetes in a community-based longitudinal study. Wang CS, Wang ST, Yao WJ, Chang TT, Chou P, Am J Epidemiol 2007 166 2 196 203 10.1093/aje/kwm061 17496314 (Pubitemid 47227286)
24. Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus. Veldt BJ, Chen W, Heathcote EJ, Wedemeyer H, Reichen J, Hofmann WP, de Knegt RJ, Zeuzem S, Manns MP, Hansen BE, Schalm SW, Janssen HL, Hepatology 2008 47 6 1856 62 10.1002/hep.22251 18506898 (Pubitemid 351945553)
25. Diabetes is the main factor accounting for the high ferritin levels detected in chronic HCV infection. Lecube A, Hernandez C, Genesca J, Esteban J, Diabetes Care 2004 27 11 2669 75 10.2337/diacare.27.11.2669 15505003 (Pubitemid 39441468)
26. Investigation on the incidence of diabetes in chronic hepatitis C patients and their HCV genotypes. Zhao P, Wang JB, Jiao J, Zhonghua Gan Zang Bing Za Zhi 2006 14 2 86 8 16494773
27. Liver cirrhosis and DM. Del Olmo JA, Serra MA, Rodrigo JM, J Hepatol 1996 24 645 8773923
28. Diabetes mellitus in Egypt: risk factors and prevalence. Herman WH, Ali MA, Aubert RE, Engelgau MM, Kenny SJ, Gunter EW, Malarcher AM, Brechner RJ, Wetterhall SF, DeStefano F, Thompson TJ, Smith PJ, Badran A, Sous ES, Habib M, Hegazy M, abd el Shakour S, Ibrahim AS, el Moneim el Behairy A, Diabet Med 1995 12 1126 1131 10.1111/j.1464-5491.1995.tb00432.x 8750225 (Pubitemid 26009956)
29. Incidence and prevalence rates of diabetes mellitus in Italy from routine data: a methodological assessment. Garancini P, Gallus G, Calori G, Formigaro F, Micossi P, Eur J Epidemiol 1991 7 1 55 63 2026224
30. The burden of diabetes and impaired glucose tolerance in India using the WHO 1999 criteria: prevalence of diabetes in India Study (PODIS). Sadikot SM, Nigam A, Das S, Bajaj S, Zargar AH, Sosale A, Diabetes Res Clin Pract 2004 66 301 10.1016/j.diabres.2004.04.008 15609460 (Pubitemid 39469376)
31. Hepatitis C viremia increases the association with type 2 DM in a Hepatitis B and C endemic area: an epidemiological link with virological implication. Huang JF, Dai CY, Hwang SJ, Ho CK, Am J Gastroenterol 2007 102 6 1237 43 10.1111/j.1572-0241.2007.01181.x 17531012 (Pubitemid 46802026)
32. Fibrsis in chronic hepatitis C correlates significantly with body mass index and steatosis. Hourigan LF, Macdonald GA, Purdie D, Hepatology 1999 29 1215 1219 10.1002/hep.510290401 10094967 (Pubitemid 29168757)
33. Glycemic homeostasis in chronic viral hepatitis and liver cirrhosis. Custro N, Carrocio A, Ganci A, Scafidi V, Campagna P, Di Prima L, Monalto G, Diabetes Metab 2001 27 4Pt1 476 81 11547221 (Pubitemid 32852456)
34. Hepatitis C infection & type 2 D in American-Indian women. Wilson C, Diab Care 2004 27 9 2116 9 10.2337/diacare.27.9.2116 (Pubitemid 39167172)
35. Incidence of type 2 diabetes mellitus and glucose abnormalities in patients with chronic hepatitis C infection by response to treatment: results of a cohort study. Giordanino C, Bugianesi E, Smedile A, Ciancio A, Abate ML, Olivero A, Pellicano R, Cassader M, Gambino R, Bo S, Ciccone G, Rizzetto M, Saracco G, Am J Gastroenterol 2008 103 10 2481 7 10.1111/j.1572-0241.2008.02002. x 18702647
36. HCV-related chronic liver disease co-factors that determine the severity and prognosis. Eissa NA, Ghonaim M, ElBanna H, Bakr A, Mostafa MS, Shoeib S, AbdelMoteleb T, Egy J Med Microbiol 2003 12 1 123 33
37. Anti-hepatitis C virus-positive blood donors: are women any different? Narciso-Schiavon JL, Schiavon LL, Carvalho-Filho RJ, Freire FC, Cardoso JR, Bordin JO, Silva AE, Ferraz ML, Transfus Med 2008 18 3 175 83 10.1111/j.1365-3148.2008.00859.x 18598280 (Pubitemid 351847333)
38. Hepatitis C as a risk factor for diabetes type 2: lack of evidence in a hospital in central-west Brazil. Corrêa da Costa LM, Mussi AD, Brianze MR, Souto FJ, Braz J Infect Dis 2008 12 1 24 6 10.1590/S1413-86702008000100007 18553010
39. Smoking and alanine transferase levels in hepatitis C: implications for prevention of HCV progression. Wang CS, Wang ST, Chang TT, Arch Intern Med 2002 162 811 15 10.1001/archinte.162.7.811 11926856
40. Prevalence and determinants of diabetes mellitus among Iranian patients with chronic liver disease. Alavian SM, Hajarizadeh B, Nematizadeh F, Larijini B, BMC Endocr Disorders 2004 4 1 4 10.1186/1472-6823-4-4 (Pubitemid 39637344)
41. Association of chronic hepatitis C virus infection and DM in Korean patients. Ryu JK, Lee SB, Hong SJ, Lee S, Korean J Intern Med 2001 16 1 18 23 11417300
42. Hepatitis C: a multifaceted disease. Review of EH manifestations. Gumber SC, Chopra S, Ann Intern Med 1995 123 615 20 7677303
43. Prognostic significance of glycaemic control in patients with HBV & HCV-realated cirrhosis & DM. Kwon SY, Kim SS, Kwon KA, Chung MG, Park DK, Kim YS, Koo YS, Kim YK, Choi DJ, Kim JH, Diab Med 2005 22 11 1530 10.1111/j.1464-5491.2005.01687.x (Pubitemid 41641160)
44. Increased risk of type 2 diabetes in non-cirrhotic patients with chronic hepatitis C virus infection. Knobler H, Schihmanter R, Zifroni A, Fenakel G, Schattner A, Mayo Clin Proc 2000 75 355 359 10.4065/75.4.355 10761489 (Pubitemid 30187108)
45. DM in chronic hepatitis B & C: prevalence & potential association with the extent of liver fibrosis. Papatheodoridis GV, Savvas S, Petraki K, Manesis EK, J Vir Hep 2006 13 5 303 10 10.1111/j.1365-2893.2005.00677.x
46. Prevalence of diabetes and incidence of angiopathy in patients with chronic viral liver disease. Kuriyama S, Miwa Y, Nagaki M, Shiraki M, Toda K, Tomita E, J Clin Biochem Nutr 2007 40 116 22 10.3164/jcbn.40.116 18188413 (Pubitemid 46623813)
47. Further evidence for an association between noninsulin-dependent diabetes mellitus and chronic hepatitis C virus infection. Caronia S, Taylor K, Pagliaro L, Carr Z, PaIazzo U, Petrik Jl, Hepatology 1999 30 1059 1063 10.1002/hep.510300416 10498660 (Pubitemid 29458297)
48. Elevated liver function tests in type II DM. Harris MI, Clin Diabetes 2005 23 3 115 19 10.2337/diaclin.23.3.115 (Pubitemid 41126805)
49. Low prevalence of HCV infection in Greek diabetic patients. Sortiropoulos A, Peppas TA, Skliros E, Pappas SI, Kotsini V, Apostolou O, Diab Med 1999 16 250 2 10.1046/j.1464-5491.1999.00009.x